CHARLOTTE, N.C., April 04, 2018 -- Legacy Good Samaritan, a dedicated community leader and a medical center of national acclaim, has partnered with HIFU Prostate Services, LLC (HPS), to bring HIFU as a treatment option for localized prostate cancer to the Portland area. HPS is the leading provider of HIFU technology to physician practices in the United States.
“At Legacy Good Samaritan we are committed to making Portland a better, healthier place to live. We are proud to add HIFU to the list of procedures we offer for patients in our community because it offers men an outpatient, less invasive treatment option for prostate cancer,” said Jonathan Avery, President of Legacy Good Samaritan Medical Center.
HIFU uses focused ultrasound energy to rapidly heat and destroy tissue in the prostate. It is an accurate and precise procedure that eliminates prostatic tissue without damaging areas around the prostate. This greatly reduces the risk of side effects such as urinary incontinence and erectile dysfunction commonly seen with more invasive treatments.
Stanley Myers, MD, a urologist with Northwest Urology in Portland, treated the first patient at Legacy Good Samaritan this past week and is the most experienced HIFU physician in the pacific northwest. Dr. Myers has been using HIFU for nearly ten years to treat patients with prostate cancer.
"Thanks to the preparation, hard work, and attention to detail by the OR team, the procedure went extremely well,” said Dr. Myers. “The patient awoke with no pain and went home a few hours after the HIFU procedure.”
Last summer, a Medicare code was issued by the Centers for Medicare and Medicaid Services that may help some patients cover part of the cost of the HIFU procedure. Additional information about reimbursement may be found at https://www.hifuprostateservices.com/reimbursement.
“The number of hospitals and medical centers that offer HIFU in the US continues to grow which clearly exhibits the increasing adoption of HIFU as a treatment option for localized prostate cancer. We look forward to working with Legacy Good Samaritan to offer HIFU in their hospital,” said John Linn, chief executive officer, HIFU Prostate Services.
As a one-time, outpatient procedure, HIFU allows patients to return home the same day as their procedure and return to their normal lifestyle within a few days. HIFU may be repeated, if necessary, and can be used to treat patients that have failed radiation therapy.
About HIFU Prostate Services, LLC
HIFU Prostate Services was founded to provide access to a less invasive prostate cancer treatment option. It has the ability to eliminate cancer and preserve patient quality of life. Our mission is to deliver the highest quality of care, support, and technology to the patient and to the urology community for the treatment of localized prostate cancer using Sonablate® HIFU. The company is headquartered in Charlotte, NC and has locations in 14 cities throughout the US. Learn more at http://www.hifuprostateservices.com.
About Legacy Good Samaritan Medical Center
Located in the heart of Northwest Portland, Legacy Good Samaritan Medical Center was founded in 1875 by the Episcopal Diocese of Oregon. Today, “Good Sam” is a nationally acclaimed medical center that is home to much of Legacy Health’s highly specialized care. Good Sam is not only known for its renowned physicians and cutting-edge technology, it is also a dedicated community partner to the neighborhood it has called home for the past 140 years. From the strong partnerships with schools and faith-based organizations to the numerous wellness programs and health screenings offered throughout the year, Legacy Good Samaritan is committed to making Portland a better, healthier place to live.
Media Contact:
John Linn
(704) 248-7562
HIFU Prostate Services
Piseth Pich
(503) 413-7742
Legacy Good Samaritan Medical Center


Telegram Restored on Apple App Store After Temporary Removal
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 



